[The ocular risks of treatment of Basedow's disease (author's transl)].
作者信息
Mornex R, Pousset G, Guinet P
出版信息
Ann Endocrinol (Paris). 1974;35(1):74-8.
PMID:4138066
Abstract
摘要
相似文献
1
[The ocular risks of treatment of Basedow's disease (author's transl)].
Ann Endocrinol (Paris). 1974;35(1):74-8.
2
[Effect of radical treatment of Basedow's disease on the ocular symptoms].
Ann Endocrinol (Paris). 1974;35(1):79-81.
3
[Treatment of Basedow's disease].[突眼性甲状腺肿的治疗]
Rev Med Suisse Romande. 1975 May;95(5):325-43.
4
[Surgical treatment of Basedow's disease. Review of a series of 823 operations (author's transl)].
Ann Chir. 1978 Dec;32(10):779-87.
5
[Current concepts in the treatment of Basedow's disease].
Sem Hop. 1975;51(37-38):2265-7.
6
[Therapy of Basedow's disease].
Schweiz Rundsch Med Prax. 1988 Feb 16;77(7):143-5.
7
[Basedow's disease. Individual therapy of is great significance].
MMW Fortschr Med. 2005 Sep 1;147(35-36):47.
8
[Basedow's disease: surgery, the choice treatment].
Minerva Endocrinol. 1987 Jan-Mar;12(1):49-53.
9
Changes in TSH receptor antibody levels (TRAb) as markers of effectiveness of various therapies in Graves-Basedow's disease.促甲状腺激素受体抗体水平（TRAb）的变化作为格雷夫斯-巴塞多氏病各种治疗效果的标志物。
Ann Univ Mariae Curie Sklodowska Med. 2003;58(1):248-53.
10
[Radioiodine therapy of immune hyperthyroidism depending on age. A tenable risk even for younger patients?].
Dtsch Med Wochenschr. 1988 Jun 10;113(23):954-61. doi: 10.1055/s-2008-1067750.
Zotero 插件